The Vielight Neuro Pro 2: The Most Customizable Brain Photobiomodulation Device, Explained
Our standard Vielight Neuro brain photobiomodulation (PBM) devices pulse near-infrared light at 10 Hz (alpha) or 40 Hz (gamma) – across all their LEDs at once. That works, our standard Vielight Neuro is featured in the most published brain PBM studies and for many people it is all they need.
However, the brain is not a single-frequency system. Different networks oscillate at different rates, interact across frequency bands, and shift state over time. The Neuro Pro 2’s advanced features exist to potentially improve the efficacy through greater customizability and protocols, beyond 10 Hz and 40 Hz.
A note before we start: the capabilities described below are real and programmable on the device. However, PBM research is still developing, and these features are tools for exploration, not validated treatment protocols.
Link to the full power user / clinician’s Neuro Pro 2 guide.
Neuro Pro 2 Customizability Features
1. Cross-Frequency Coupling
What it does: Pulses two frequencies within a single LED module at the same time — for example, a 4 Hz delta rhythm carrying a 40 Hz gamma rhythm.
Why? Your brain doesn’t run on one rhythm at a time — slower and faster brainwaves work together. In the hippocampus, the brain’s memory hub, a slow rhythm sets the timing for a faster one during memory formation. The Neuro Pro 2 pulses two frequencies at once in the same module to match that layering, instead of delivering one flat note. Whether it works better than a single frequency is still being researched — but most devices can’t even attempt it.
2. Phase A/B Control
What it does: Lets you assign different LED modules to separate, asynchronous phases instead of pulsing every module in lockstep.
Why? When every light pulses in unison, the brain gets one predictable signal — and the brain quickly learns to tune predictable signals out. Phase control staggers the timing so some modules lead and others lag. This keeps the input from going stale over a session, and lets you work the connections between regions, not just the regions themselves. Most devices pulse everything at once; phase control is for users who want that variation on purpose.
3. Dynamic Frequency Sweeps
What it does: Gradually transitions stimulation across a band over the course of a session – for example, sweeping smoothly from 8 Hz to 12 Hz across the alpha range — rather than holding one static frequency.
Why? There’s no single “correct” frequency that works for everyone — your peak alpha frequency differs from the next person’s, and even shifts during the day. A fixed setting forces you to guess one exact target; a sweep moves through the whole range instead, so you’re not relying on that guess. Gently moving the stimulation rather than holding it steady is also meant to keep the brain flexible, nudging it to shift rather than lock onto one imposed rhythm. Most devices can’t do this; on the Neuro Pro 2 the sweep is automated.
4. Power Sweeps (the Arndt-Schulz principle)
What it does: Automatically ramps light intensity up or down during a session rather than holding one fixed power level.
Why? With light therapy, dose matters in both directions: too little does nothing, the right amount produces the effect you want, and too much can backfire — a pattern known as the Arndt-Schulz principle. The catch is that the ideal dose differs between people and even between regions of the head, so any fixed intensity is just a single guess. A power sweep ramps through a range of intensities instead, helping find an effective level without overshooting, while also easing fatigue over a longer session. It works with that dose-response curve rather than betting on one point of it.
5. Batch Mode Workflow (Multi-Stage Chaining)
What it does: Chains up to nine distinct stages into a single automated session — for example, a gentle warm-up, a higher-intensity peak, and a restorative cool-down — each with its own parameters.
Why? One flat setting from start to finish rarely makes the best session — the state you begin in isn’t the one you want to end in, and a single fixed protocol can’t guide that shift. Batch mode lets you script a sequence — a gentle warm-up, a peak, then a wind-down — so the session has an arc. For clinicians running structured protocols, it also means a repeatable, hands-off run instead of changing settings by hand mid-session. Simpler devices run one protocol per session; the Neuro Pro 2 lets you chain several into one.
The Gracefire Protocols: Pre-programmed
The features above are powerful, but programming a multi-stage, cross-frequency session from scratch is a lot to ask of most users. The Gracefire Protocols — a preset library designed by neuroscientists and included with the Neuro Pro 2 — package those capabilities into ready-to-run sessions, so an everyday user can benefit from the advanced features without engineering them by hand, while a clinician can still open the hood and customise further.
Rather than a single steady tone, each Gracefire protocol is built around how brain regions communicate, using the device’s specific module placements to engage particular networks — such as the Default Mode Network, the Salience Network, and the Central Executive Network. The library includes five core presets, each with a different intended focus:
- Relax & Recover — oriented toward stress management and mental relaxation.
- Focus — oriented toward cognitive adaptability and sustained attention.
- Emotional Balance — oriented toward sensory integration and feeling grounded.
- Flex — oriented toward creativity and state flexibility.
- Enhance — oriented toward processing speed and motor coordination.
More modules, stronger coverage: the hardware behind the control
Where the Vielight Neuro 4 uses five transcranial modules and a single intranasal applicator, the Neuro Pro 2 features 10 transcranial modules plus 2 intranasal applicators – roughly double the hardware. While both the standard Neuro and Neuro Pro offer full transcranial coverage, the Neuro Pro 2’s transcranial modules are positioned to offer stronger energy density across other brain networks (beyond the Default Mode Network), while the two intranasal applicators add a second delivery pathway that transcranial-only helmets do not have.
The intranasal route matters because of a quirk of anatomy. The cribriform plate — the thin, perforated bone behind the nasal cavity — is far thinner than the skull, so it offers a low-resistance path for near-infrared light to reach deep frontal and limbic structures that are difficult to illuminate from the scalp alone. Pairing transcranial and intranasal delivery (Vielight’s itPBM approach) is the design rationale for engaging the whole brain rather than the cortical surface only.
Compare the energy footprint between the Vielight Neuro and Neuro Pro 2
Independently corroborated in clinical use
Dr. Cody, a US Navy-trained psychiatrist who uses the device clinically and runs a coaching program built around it, reviewed the Neuro Pro 2 after six months of use and independently described the same capabilities in practice – per-module frequency from 1 Hz to nearly 10,000 Hz, power from 1% to 140%, pulsing, sweep modes, multi-stage batch runs, and module-level targeting. He specifically noted theta–gamma cross-frequency coupling as a capability the Neuro Pro 2 offers that simpler devices do not.
How it compares
The clearest way to see the difference is feature by feature, across the devices people most often weigh against each other. The table below reflects each manufacturer’s own published documentation.
Customizability comparison across three brain PBM helmets
The Neuradiant 1070 and the Suyzeko 810 nm helmet are both based on the Suyzeko LED architecture.
The Neuro Pro 2 is built for granular, per-module control. The rows below reflect each manufacturer’s own published documentation.
Note that a wide raw frequency range is not the same as fine-grained temporal and spatial control — the advanced features at the top of this table are what distinguish precision neural engineering from single-tone pulsing.
| Control feature | Vielight Neuro Pro 2 | Neuronic Neuradiant 1070 | Suyzeko 810 nm helmet |
|---|---|---|---|
| Cross-frequency coupling | Yes — two frequencies in one module simultaneously (e.g. 4 Hz + 40 Hz). | Not documented. | Not documented. |
| Phase control | Asynchronous A/B phases assignable per module. | Global, synchronous pulsing. | Global, synchronous pulsing. |
| Automated frequency sweeps | Programmable transitions across a band (e.g. 8–12 Hz). | Not documented; fixed/selectable frequencies. | Not documented; fixed/selectable frequencies. |
| Automated power sweeps | Yes — intensity ramping (Arndt-Schulz dose-response). | Stepped intensity; no documented ramping. | Four fixed power levels (25/50/75/100%); no documented ramping. |
| Multi-stage sessions | Chain up to 9 stages into one session (warm-up → peak → cool-down). | Single protocol per session. | Single protocol per session. |
| Spatial targeting | Module-by-module, across 10 transcranial + 2 intranasal modules. | Four-quadrant (front / back / left / right) regional control. | Whole-helmet; no documented regional control. |
| Delivery pathway | Transcranial + intranasal. | Transcranial only. | Transcranial only. |
| Pulse frequency range | 1 Hz – ~10,000 Hz, set independently per module. | 0 – 999 Hz, single global setting (Custom protocol). | 1 – 20,000 Hz, single global setting. |
Neuradiant and Suyzeko specifications per each manufacturer’s published product documentation (neuronic.online and suyzeko.com, verified June 2026).
Why 810 nm: Mitochondria and Penetration
Every Vielight Neuro device, including the Neuro Pro 2, uses 810 nm near-infrared light. That number isn’t arbitrary – it’s chosen to match the biology of how light interacts with the brain, and it’s one of the clearer points of difference from the 1070 nm helmets on the market.
The target is an enzyme inside your cells’ mitochondria called cytochrome c oxidase, which is what near-infrared light acts on to support energy (ATP) production. That enzyme absorbs light most strongly at around 800 nm — right where 810 nm sits. Longer wavelengths like 1064 and 1070 nm fall outside that absorption peak, so they engage this mechanism less directly.
There’s also a delivery problem at the longer wavelengths. The brain is roughly 70–80% water, and 1070 nm light is absorbed much more strongly by water than 810 nm is. So more of a 1070 nm beam is soaked up by tissue water before it reaches its target, while 810 nm sits in what researchers call the body’s “optical window” — the range that passes through tissue most efficiently.
Independent measurements bear this out. A 2025 study in the journal Brain Stimulation (Tittelmeier et al.) measured how much light from two commercial helmets — one 810 nm, one 1070 nm, neither made by Vielight — actually passed through human head tissue. The 810 nm helmet transmitted about 2.2× more than the 1070 nm one (0.71% vs 0.45% of emitted light through the tested tissue). Separate dosimetry work from Harvard Medical School and Peking University points the same way: 810 nm reached the cortex more effectively than 1064/1070 nm across the conditions they tested. In short, a longer wavelength does not mean deeper delivery.
One caveat worth keeping in view: that Brain Stimulation study also found both tested helmets — the 810 nm one included — delivered too little light after skull attenuation to reliably drive the mitochondrial mechanism. The takeaway isn’t that 810 nm alone is sufficient; it’s that the right wavelength has to be paired with enough irradiance and a delivery design that limits skull losses. That pairing — 810 nm at high surface irradiance, in direct scalp contact, plus the intranasal pathway — is the whole point of the Vielight approach, and it’s why the next section on irradiance matters as much as the wavelength.
Why irradiance matters as much as the control: a note on irradiance
Programmability determines what you do with the light. But none of it matters unless enough light actually reaches brain tissue in the first place — and that is a question of irradiance, not total power.
- Total power (mW) is the sum of all light a device emits, and it can be inflated simply by adding more weak LEDs.
- Irradiance, or surface power density (mW/cm²), is the concentration of light landing on a given area of tissue — and it is what determines how deeply the light penetrates the scalp and skull. Because of the inverse square law, light intensity falls off with the square of the distance from its source: a helmet that holds its LEDs centimetres from the scalp behind diffuser layers can advertise a high total power while delivering only a fraction of it to the tissue.
Measured irradiance at the scalp
Irradiance (surface power density) determines how much light actually reaches brain tissue — far more meaningful than total wattage. The figures below come from independent photonics laboratories using calibrated instruments, compared against each device’s own declared specification. Notably, the Neuradiant 1070 is built on the same Suyzeko OEM helmet platform, which helps explain their similar measured results.
| Measurement | Standard Vielight Neuro (not Neuro Pro 2) | Neuronic Neuradiant 1070 | Suyzeko 810 nm helmet |
|---|---|---|---|
| Declared irradiance | 75 (frontal) / 100 mW/cm² (rear) | 20 – 40 mW/cm² | 24 mW/cm² |
| Measured irradiance (Optronic Labs) | ~277.5 mW/cm² (avg) | ~6.22 mW/cm² | ~4.74 mW/cm² |
| Measured irradiance (MegaLabs) | ~208 – 302 mW/cm² (per module) | ~12.1 mW/cm² | Not tested in this report |
| Declared vs. measured | Measured above declared | −79% vs. declared | −81% vs. declared |
| Measured peak wavelength | ~810 nm (as declared) | ~1055–1059 nm (1070 declared) | ~811 nm (810 declared) |
Irradiance and wavelength figures per the PBM Foundation device testing program: Optronic Labs (NIST-traceable spectroradiometer) and MegaLabs / Light Matter Interaction Inc. (calibrated spectrometer and power meter), 2024. The two labs used different equipment and geometry, so figures differ but agree in direction. For context, a 2024 systematic review reported ~250 mW/cm² as typical in published brain PBM research. These reports tested the Vielight Neuro, not the newer Neuro Pro 2.
Those reports tested the Vielight Neuro, not the newer Neuro Pro 2. The Neuro Pro 2 is engineered to deliver approximately 30% more total output than the Vielight Neuro (a Vielight design figure), across 10 transcranial and 2 intranasal modules. The reason the Vielight form factor measures so well applies to the Pro 2 too: the modules sit in direct contact with the scalp, minimising the inverse-square losses that undermine helmet-style devices with rigid panels.
Built for the clinic: the Neuro Pro 2
The research above was generated with Vielight devices in real clinical and academic settings — and the Neuro Pro 2 is the version engineered specifically for practitioners who want to move beyond fixed, one-size-fits-all settings. Where consumer devices offer a handful of preset programs, the Pro 2 gives clinicians the granular control to tailor a session to the person in front of them.
Specifications per Vielight’s Neuro Pro 2 Practitioner’s Guide. The Pro 2 pairs 10 scalp-mounted near-infrared LEDs with 2 intranasal LEDs for the combined intranasal-transcranial (itPBM) delivery used across most of the studies above.
Why practitioners choose it
Per-LED control, not presetsTurn individual LEDs on or off, set frequency per LED, run frequency sweeps (e.g. across the alpha band) and power sweeps, and activate modules in any combination — including for asymmetric presentations where one region needs different handling than another. | Network-based targetingLED placement is mapped to large-scale brain networks — the default mode, salience, and central executive networks central to attention, regulation, and cognitive switching — so clinicians can think in terms of engaging whole networks rather than isolated points. |
Advanced temporal toolsCross-frequency coupling, phase control, duty-cycle adjustment, and frequency pulsing from 1 to 10,000 Hz give the temporal precision needed to explore protocols beyond steady-state stimulation. | The intranasal advantage, retainedThe two intranasal LEDs reach frontal and limbic areas with minimal bone interference — the same itPBM pathway that the neuroimaging studies above show is dramatically more efficient than scalp-only delivery. |
Fits into an existing practice
The Pro 2 ships with a clinician-facing app offering guided preset protocols for practitioners who want a starting point, alongside the full manual interface for those who want to build their own. It’s designed to integrate alongside modalities like neurofeedback rather than replace them — clinicians can use presets for routine sessions and the granular controls when a case calls for something specific. Vielight publishes a dedicated Practitioner’s Guide and Clinician’s Guide covering device principles, protocol libraries, and integration strategies.
Bringing PBM into your practice?
Note for practitioners. Vielight Neuro devices are categorized by the FDA as general wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Clinical integration should follow applicable professional and regulatory guidelines in your jurisdiction. Photobiomodulation is generally well tolerated; Vielight advises against use with active brain bleeds or a history of seizures, and pregnant women should consult a healthcare provider first.
The bottom line
Two things determine whether a brain PBM device works for you: how much light reaches the tissue, and how precisely you can shape that light. The Neuro Pro 2 is built for both — the most programmable device in a product line that independent labs have measured at the top of the field for delivered irradiance. The depth of control carries a learning curve, and many users are well served by a simpler alpha/gamma device. But for clinicians and advanced users who want to move beyond presets, most devices offer a switch; the Neuro Pro 2 offers a console.
The Vielight Neuro Pro 2 is a general wellness device. It is not intended to diagnose, treat, cure, or prevent any disease. The mechanisms described above represent the design rationale behind each feature and are areas of ongoing research, not established clinical outcomes.